Literature DB >> 3610050

Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geese.

P L Marion, J M Cullen, R R Azcárraga, M J Van Davelaar, W S Robinson.   

Abstract

We investigated experimental transmission of duck hepatitis B virus to its original host, the domestic Pekin duck, and to three other avian species. Intramuscular injection of a standard inoculum of duck hepatitis B virus into 2- to 5-day-old Pekin ducklings hatched from a duck hepatitis B virus-free flock resulted in viremia in 100% of 107 animals, indicating that duck hepatitis B virus infection of young progeny of a defined duck hepatitis B virus-free flock occurs reproducibly. When the same inoculum was injected into chicks and Muscovy ducklings of the same age, no evidence of viral infection was detectable. In contrast, hatchlings of two domestic breeds of geese were readily infected by duck hepatitis B virus, developing viremia at a slower rate than Pekin ducklings, but a higher average titer of viremia 4 weeks or more after injection. Neither the pattern of restriction enzyme sites in the viral DNA nor the susceptibility of ducklings to the virus were detectably altered after passage in geese. As in duck hepatitis B virus-infected young ducklings, most of the experimentally infected goslings appeared to be persistently infected and those eventually laying eggs transmitted virus to the progeny. While ducklings exhibited a fairly uniform inflammatory response to the virus, duck hepatitis B virus inoculation of the goslings resulted in both inflammation and an altered hepatocellular morphology not seen in uninjected controls. The host range of duck hepatitis B virus appears to be limited to the primary host and a close taxonomic relative, similar to other members of the hepadnavirus family, hepatitis B virus and ground squirrel hepatitis virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3610050     DOI: 10.1002/hep.1840070418

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Potent efficacy of entecavir (BMS-200475) in a duck model of hepatitis B virus replication.

Authors:  Patricia L Marion; Felix H Salazar; Mark A Winters; Richard J Colonno
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels.

Authors:  R C Tam; K Ramasamy; J Bard; B Pai; C Lim; D R Averett
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

3.  Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus.

Authors:  R C Cheung; W S Robinson; P L Marion; H B Greenberg
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

Review 4.  Is hepatitis B-virucidal validation of biocides possible with the use of surrogates?

Authors:  Andreas Sauerbrei
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

5.  Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles.

Authors:  J C Pugh; Q Di; W S Mason; H Simmons
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  Duck hepatitis B virus infection of Muscovy duck hepatocytes and nature of virus resistance in vivo.

Authors:  J C Pugh; H Simmons
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

7.  New hepatitis B virus of cranes that has an unexpected broad host range.

Authors:  Alexej Prassolov; Heinz Hohenberg; Tatyana Kalinina; Carola Schneider; Lucyna Cova; Oliver Krone; Kai Frölich; Hans Will; Hüseyin Sirma
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity.

Authors:  Pramod P Naranatt; Shaw M Akula; Christopher A Zien; Harinivas H Krishnan; Bala Chandran
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes.

Authors:  Kai Dallmeier; Ursula Schultz; Michael Nassal
Journal:  PLoS Pathog       Date:  2008-12-05       Impact factor: 6.823

10.  Does limited virucidal activity of biocides include duck hepatitis B virucidal action?

Authors:  Andreas Sauerbrei; Michael Schacke; Brigitte Glück; Uwe Bust; Holger F Rabenau; Peter Wutzler
Journal:  BMC Infect Dis       Date:  2012-10-30       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.